RAPIVAB Trademark

Trademark Overview

On Thursday, December 12, 2013, a trademark application was filed for RAPIVAB with the United States Patent and Trademark Office. The USPTO has given the RAPIVAB trademark a serial number of 86141883. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, June 24, 2022. This trademark is owned by BioCryst Pharmaceuticals, Inc.. The RAPIVAB trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical antiviral preparation
rapivab

General Information

Serial Number86141883
Word MarkRAPIVAB
Filing DateThursday, December 12, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, June 24, 2022
Registration Number4778059
Registration DateTuesday, July 21, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 4, 2014

Trademark Statements

Goods and Servicespharmaceutical antiviral preparation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 26, 2013
Primary Code005
First Use Anywhere DateThursday, January 15, 2015
First Use In Commerce DateThursday, January 15, 2015

Trademark Owner History

Party NameBIOCRYST PHARMACEUTICALS, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDURHAM, NC 27703
Party NameSEQIRUS UK LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDurham, NC 27703
Party NameBioCryst Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35244
Party NameBioCryst Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35244
Party NameBioCryst Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBirmingham, AL 35244

Trademark Events

Event DateEvent Description
Friday, March 21, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 16, 2013NEW APPLICATION ENTERED
Thursday, December 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 21, 2014ASSIGNED TO EXAMINER
Friday, March 21, 2014NON-FINAL ACTION WRITTEN
Friday, March 21, 2014NON-FINAL ACTION E-MAILED
Tuesday, December 30, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 12, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 12, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, September 13, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, September 13, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 25, 2014ASSIGNED TO LIE
Tuesday, September 30, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 15, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 4, 2014PUBLISHED FOR OPPOSITION
Tuesday, November 4, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, June 4, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 11, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 12, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 21, 2015REGISTERED-PRINCIPAL REGISTER
Friday, February 17, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 7, 2015TEAS STATEMENT OF USE RECEIVED
Thursday, May 7, 2015USE AMENDMENT FILED
Tuesday, June 9, 2015STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 28, 2016AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, February 17, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 23, 2017TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 23, 2017APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, September 23, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, September 23, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 21, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, April 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 6, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 6, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 19, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 22, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 24, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, February 23, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, June 24, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, July 21, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

rapivab preparation antiviral pharmaceutical